Licht, J D <br/><br/>
Treatment of low-grade and intermediate-grade lymphoma with intensive combination chemotherapy results in long-term, disease-free survival.  [electronic resource] 

 -  Cancer  Aug 1990 
 - 632-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19900815)66:4<632::aid-cncr2820660405>3.0.co;2-b  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bleomycin--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lymphoma--drug therapy<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neoplasm Staging<br/>Recurrence<br/>Remission Induction<br/>Survival Rate<br/>Vincristine--administration & dosage